Interventional Psychiatry

Transcranial Magnetic Stimulation (TMS)

Mindfully Integrated Health has partnered with NeuroStar to provide TMS Therapy. TMS is an FDA-approved treatment for patients with severe treatment resistant depression. TMS therapy has been included in the American Psychiatric Association treatment guideline for depression since 2010 and offers a drug free way to manage depression!

TMS uses precisely targeted magnetic pulses to stimulate key areas of the brain that are underactive in patients with depression.

Facts about NeuroStar TMS Treatment:

  • It is an in-office treatment

  • Patients are awake and alert throughout the treatment

  • Patients can go back to their normal activities immediately after treatment

  • It takes approximately 20 minutes

  • Treatment is administered 5 days a week, for approximately 6 weeks

NeuroStar® clinical results and ongoing clinical trials:

NeuroStar TMS Therapy has the largest clinical data set of any TMS treatment. Clinical studies with over 900 patients have shown that NeuroStar TMS Therapy can help achieve remission for patients living with severe depression.

  • 1 in 2 patients experienced significant improvement

  • 1 in 3 patients achieved full remission

In an NIMH-funded, independent, randomized controlled trial, patients treated with TMS using the NeuroStar TMS System were four times more likely to achieve remission compared to patients receiving sham treatment.


Ketamine Infusion Therapy

Every year, it is estimated that 13 - 14 million Americans suffer from major depression. Of those who seek treatment, 30% to 40% will not get better or fully recover with standard medication management. This is referred to as treatment resistant depression. Untreated or poorly treated depression puts the individual at greater risk for substance abuse, hospitalization, or suicide.

Ketamine infusion therapy has been shown to be successful in treating patients suffering from major depression, bipolar depression, postpartum depression (PPD), obsessive-compulsive disorder (OCD), posttraumatic stress disorder (PTSD), generalized anxiety disorder (GAD), and chronic pain syndromes like complex regional pain syndrome (CRPS). Ketamine acts by binding receptors in the brain and acts to enhance the production of neurotransmitters, such as serotonin, which in turn alleviates depressive symptoms. Ketamine effectively "re-wires" the brain, resulting in an antidepressant effect that is significantly different from the traditional antidepressant medication, which may reduce the need for other psychiatric medications.

Check out Mindfully Integrated Health's resources page for links to research on the efficacy of Ketamine infusion therapy for psychiatric disorders.